Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Ullrich congenital muscular dystrophy

Other Names for this Disease
  • Late onset scleroatonic familial myopathy (subtype)
  • Scleroatonic muscular dystrophy
  • UCMD
  • Ullrich disease
  • Ullrich scleroatonic muscular dystrophy
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might Ullrich muscular dystrophy be treated?

Physical therapy, including early mobilization, regular stretching and splinting, is the main focus of supportive care. Respiratory support and night-time ventilation often becomes necessary in the first or second decade of life. Prevention of chest infections may be achieved with the use of antibiotics. Feeding difficulties leading to failure to thrive may be managed by gastrostomy. Surgery may be needed for contractures and scoliosis.[1][2] Some reports indicate that people with Ullrich congenital muscular dystrophy may may benefit from cyclosporin A. More studies into the benefits of this therapy are needed.[2]
Last updated: 3/4/2014

  1. Lampe AK, Flanigan KM, Bushby KM, Hicks D. Collagen Type VI-Related Disorders. GeneReviews. August 9, 2012; Accessed 3/4/2014.
  2. Eymard B. Congenital muscular dystrophy, Ullrich type. Orphanet. Accessed 3/4/2014.

Management Guidelines

  • GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.

Clinical Trials & Research for this Disease

  • lists trials that are studying or have studied Ullrich congenital muscular dystrophy. Click on the link to go to to read descriptions of these studies.